These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Biotechnology financing dilemmas and the role of special purpose entities. Schiff L; Murray F Nat Biotechnol; 2004 Mar; 22(3):271-7. PubMed ID: 14990945 [No Abstract] [Full Text] [Related]
11. New biotech hubs may emerge as industry matures. Basu P Nat Biotechnol; 2003 Oct; 21(10):1123. PubMed ID: 14520385 [No Abstract] [Full Text] [Related]
13. The other side of being CFO. Benner K Fortune; 2012 Oct; 166(6):58. PubMed ID: 23072075 [No Abstract] [Full Text] [Related]
14. Let the chips fall where they may. Jacobs T Nat Biotechnol; 2003 Feb; 21(2):129. PubMed ID: 12560829 [No Abstract] [Full Text] [Related]
15. Biotechs hold their own in shifting industry. Mitchell P Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238 [No Abstract] [Full Text] [Related]
16. When your stock takes a nosedive. Jacobs T Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152 [No Abstract] [Full Text] [Related]
18. Any diamonds in the diagnostic coal? Jacobs T Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133 [No Abstract] [Full Text] [Related]
19. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]